The first purchasing issue is the strength: the established depot presentation is triptorelin 3.75 mg, not 375 mg. By checking the formulation, clinical use, handling records and Chilean authorization pathway, you can determine whether a quotation is for the correct medicine and whether the proposed supplier can support a lawful institutional purchase.
Key takeaways
- Treat “375 mg” as an error until the vial and approved information confirm it.
- Match the indication, route and reconstitution instructions to the approved presentation.
- Request expiry, batch, storage and temperature-excursion records before purchase.
- Check the Chilean registration and identify the importer and responsible local party.
Correct the 375 mg specification before requesting quotations
375 mg is not the usual monthly depot strength: it is 100 times the quantity of 3.75 mg. Treat “375 mg” as a transcription or specification error until the vial label and approved product information confirm it.
- Request a quotation for triptorelin 3.75 mg, stating the active-ingredient form, pharmaceutical form, depot status, administration route, brand or proposed trade name, and complete vial-and-diluent presentation.
- Ask for a clear vial and carton photograph, certificate of analysis, and product information. Use these documents to distinguish 3.75 mg from 0.375 mg, 11.25 mg, and 22.5 mg depot products.
- Require the supplier to reconcile the salt or formulation name with the Chilean registration record and package insert. Do not assume that “acetate” identifies the same product as a depot triptorelin pamoate formulation.
- Confirm that the quotation includes the powder, specified diluent, reconstitution device where supplied, and package insert—not only a vial.
Describe the intended product as a monthly-strength depot presentation, not simply an injection. For searches and tenders, use the wording “triptorelin 3 point 75 mg injection supplier in Santiago.” Do not issue a purchase order until the strength, formulation, route, presentation, and Chilean product record match.
Match the indication, route and preparation to the approved presentation
A quoted 3.75 mg depot is suitable only when its indication, patient group, dosing interval and contraindications match the Chilean product information for that exact presentation. Registered uses can include prostate cancer, endometriosis, uterine fibroids or selected assisted-reproduction protocols; do not transfer an indication from foreign marketing material.
This is not automatically a daily formulation or interchangeable with 0.375 mg, 11.25 mg or 22.5 mg products. A 3.75 mg depot is supplied as powder with a specified diluent, not as a ready-to-use liquid. For any search such as “buy triptorelin injection chile,” require the complete pack and approved instructions.
- Obtain the sealed vial, specified diluent, reconstitution device where supplied, and Spanish or otherwise approved package insert.
- Have the administering healthcare professional follow the stated route, needle, diluent and reconstitution sequence. Never infer the route from “injection,” administer intravenously unless the approved information explicitly permits it, or reuse a reconstituted depot.
- For prostate-cancer protocols, check the initial gonadotropin and sex-hormone flare. It can worsen spinal-cord compression or ureteral obstruction in patients at risk, so the protocol must address flare management.
- Confirm pregnancy and breastfeeding warnings, patient eligibility and contraindications before supply or administration.
- Do not describe triptorelin as routine contraception or as a fertility medicine merely because selected assisted-reproduction protocols use it.
If the supplier cannot provide the exact leaflet and complete preparation, stop the clinical and purchasing review.
Verify temperature control, expiry and batch traceability
A shipment remains usable only when its storage history supports the exact triptorelin SKU from dispatch through administration. Request the approved label’s temperature range and light-protection instruction; do not infer either requirement from the fact that the product is injectable.
Ask the supplier for:
- Transport qualification and, when required, data-logger or temperature-monitoring records.
- Written instructions for evaluating and reporting a temperature excursion, including whether the batch must be quarantined.
- The maximum permitted time and conditions after reconstitution. A sealed powder-and-diluent pack is still unacceptable if its storage history cannot be verified.
- The batch number, manufacturing date, expiry date and certificate of analysis before release.
- The procedure for rejected batches, recalls, complaints and replacement after an excursion.
Compare expiry with the complete delivery timeline:
| Offered dating | Operational risk | Purchasing decision |
|---|---|---|
| Short remaining shelf life | Customs clearance or delayed use can leave unusable stock | Reject unless the supplier replaces or extends the lot under an approved procedure |
| Adequate remaining shelf life | Allows Santiago customs clearance, receiving checks and planned administration | Accept when temperature records and batch documents are complete |
| Longer remaining shelf life | Reduces wastage and repeat purchasing | Prefer when the price difference is smaller than the cost of disposal |
Put the minimum remaining shelf life in the purchase order, and require written acceptance of the excursion and replacement terms before dispatch.
Confirm the Chilean authorization and the responsible local party
An export quotation is not permission to sell or administer the medicine in Chile. A search for triptorelin acetate importer chile identifies a commercial lead, not a lawful market pathway.
1. Ask the Instituto de Salud Pública de Chile and ANAMED for written confirmation covering the exact manufacturer, product name, strength, pharmaceutical form, route, indication and registration holder. Reconcile the generic name with the registered name, including the triptorelin salt, depot presentation and vial configuration.
2. Confirm whether the shipment uses the ordinary sanitary-registration route or a specific authorization for an unregistered medicine or named-patient supply. A certificate of pharmaceutical product, foreign export certificate or WHO-GMP evidence can support review, but none proves Chilean authorization to market the finished medicine.
3. Put each Chilean responsibility in writing: importer of record, local licence holder, import and batch-release party, Spanish-label manager, pharmacovigilance contact, recall coordinator and market-complaint handler. The Indian manufacturer or exporter, Chilean registration holder, importer and Santiago distributor are separate parties; naming only the overseas supplier leaves the legal chain incomplete.
4. Retain the ISP or ANAMED authorization, customs entry, commercial invoice, packing list and import records with the batch file. Recheck the position before each procurement because registration status, import conditions and product requirements can change. Do not release stock for sale or administration until the authorized Chilean parties confirm the pathway and responsibilities.
Use a document-based tender to choose the Santiago supply partner
Compare bidders against one written specification, not against catalogue language. State triptorelin 3.75 mg, the exact active-ingredient form, depot presentation, indication, route, complete vial-and-diluent pack, minimum remaining shelf life and delivery temperature controls. This gives a triptorelin injection distributor in Santiago and an overseas manufacturer the same test.
Request these documents from every bidder:
- ISP sanitary registration or the applicable Chilean authorization for the exact product, plus the registration holder’s name
- Certificate of analysis, batch-release documentation and certificate of pharmaceutical product
- Current good manufacturing practice evidence and safety data sheet
- Spanish product information, including approved indication, route and reconstitution instructions
- Commercial invoice, packing list and certificate of origin
Ask the local bidder to name its Chilean licence, importer-of-record role, batch-traceability system, temperature-excursion procedure and recall contact. Confirm who performs importation, local labelling, release, pharmacovigilance and complaint handling.
| Bidder type | Evidence to compare | Decision point |
|---|---|---|
| Chilean distributor | Licence, ISP pathway, traceability, recall and excursion records | Accept only with a named importer and registration holder |
| Overseas exporter or manufacturer | GMP evidence, batch documents, product identity and origin records | Accept only after the Chilean party confirms authorization and import responsibility |
NIBA HEALTHCARE can be one quotation source for Indian finished-pharmaceutical supply, but assess its offer against these documents. Do not issue a purchase order until supplier, importer and distributor duties are written down and the Chilean pathway is confirmed.
Related product
 | Anti Cancer Injection Triptorelin Acetate 3.75 Mg Injection Minimum order quantity 10 Vial Packaging Size 1 ml Packaging Type Vial Brand Decapeptyl Manufacturer Ferring Pharmaceuticals Country of Origin Made... View product → |
Frequently asked questions
Is 375 mg the usual triptorelin depot injection strength?
No. 375 mg is 100 times 3.75 mg, so treat the specification as a transcription error until the vial label and approved product information confirm it.
What should you verify before buying triptorelin injection in Chile?
Verify the approved strength, indication, route, preparation instructions, Chilean registration, importer and responsible local party.
What temperature and traceability records should a Santiago supplier provide?
Request the labelled storage range, expiry date, batch number, certificate of analysis and shipment temperature records, including any excursion report.
How should you compare triptorelin suppliers in Santiago?
Use a document-based tender that compares the approved presentation, authorization evidence, cold-chain records, batch traceability, delivery terms and after-sales documentation.
